Gillian E. Stillfried

A structural basis for differential cell signalling by PAI-1 and PAI-2 in breast cancer cells.

David R. Croucher, D. Croucher, D. Saunders, 2007, The Biochemical journal.

Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity

D. Saunders, M. Ranson, Gillian E. Stillfried, 2007, Breast Cancer Research.

Preclinical evaluation of 213Bi-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinoma

David R. Croucher, D. Croucher, F. Al-Ejeh, 2007, Molecular Cancer Therapeutics.

Preclinical evaluation of Bi-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinoma

D. Croucher, F. Al-Ejeh, M. Links, 2007 .

Preclinical evaluation of 213 Bi-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinoma

D. Croucher, F. Al-Ejeh, M. Links, 2007 .

Comparative effectiveness of 5-fluorouracil with and without oxaliplatin in the treatment of colorectal cancer in clinical practice.

J. Dawber, M. Ranson, Gillian E. Stillfried, 2013, Anticancer research.

‘I want to feel at home’: establishing what aspects of environmental design are important to people with dementia nearing the end of life

Gillian E. Stillfried, Fiona Kelly, R. Fleming, 2015, BMC Palliative Care.

Urokinase-dependent plasminogen binding and activation on breast cancer cells: an important process linked to malignancy

Gillian E. Stillfried, 2007 .